Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Virgen CA"'
Autor:
Fellon CM; Corey M. Fellon, BS, Albany Medical College, Albany, NY; Ashley N. Elsensohn, MD, MPH, Loma Linda University, Department of Dermatology, Loma Linda, CA, Loma Linda University, Department of Pathology, Loma Linda, CA; Christina N. Kraus, MD, University of California, Irvine, Department of Dermatology, Irvine, CA; and Cesar A. Virgen, MD, PhD, Department of Dermatology, Brigham and Women's Hospital, Boston, MA, Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA., Elsensohn AN; Corey M. Fellon, BS, Albany Medical College, Albany, NY; Ashley N. Elsensohn, MD, MPH, Loma Linda University, Department of Dermatology, Loma Linda, CA, Loma Linda University, Department of Pathology, Loma Linda, CA; Christina N. Kraus, MD, University of California, Irvine, Department of Dermatology, Irvine, CA; and Cesar A. Virgen, MD, PhD, Department of Dermatology, Brigham and Women's Hospital, Boston, MA, Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA., Kraus CN; Corey M. Fellon, BS, Albany Medical College, Albany, NY; Ashley N. Elsensohn, MD, MPH, Loma Linda University, Department of Dermatology, Loma Linda, CA, Loma Linda University, Department of Pathology, Loma Linda, CA; Christina N. Kraus, MD, University of California, Irvine, Department of Dermatology, Irvine, CA; and Cesar A. Virgen, MD, PhD, Department of Dermatology, Brigham and Women's Hospital, Boston, MA, Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA., Virgen CA; Corey M. Fellon, BS, Albany Medical College, Albany, NY; Ashley N. Elsensohn, MD, MPH, Loma Linda University, Department of Dermatology, Loma Linda, CA, Loma Linda University, Department of Pathology, Loma Linda, CA; Christina N. Kraus, MD, University of California, Irvine, Department of Dermatology, Irvine, CA; and Cesar A. Virgen, MD, PhD, Department of Dermatology, Brigham and Women's Hospital, Boston, MA, Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 01; Vol. 42 (22), pp. 2723-2724. Date of Electronic Publication: 2024 May 22.
Autor:
Swallow MA; Yale School of Medicine, New Haven, CT, USA., Virgen CA; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
International journal of dermatology [Int J Dermatol] 2024 Jun; Vol. 63 (6), pp. e115-e116. Date of Electronic Publication: 2024 Apr 12.
Autor:
Jfri A; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Virgen CA; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Center for Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Tawa M; Center for Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Giobbie-Hurder A; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Kupper TS; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Center for Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Fisher DC; Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., LeBoeuf NR; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Center for Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Larocca C; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Center for Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. Electronic address: CLarocca@BWH.Harvard.edu.
Publikováno v:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Nov; Vol. 89 (5), pp. 1044-1047. Date of Electronic Publication: 2023 Jun 13.
Autor:
Said JT; Departments of Dermatology.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology., Iriarte C; Departments of Dermatology.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology., Talia J; Departments of Dermatology., Leung B; Departments of Dermatology.; Center for Cutaneous Oncology., Virgen CA; Departments of Dermatology.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology., Robertson M; Harvard Medical School, Boston, MA, USA.; Radiology, Brigham and Women's Hospital, Boston, MA, USA., Rabin MS; Harvard Medical School, Boston, MA, USA.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Larocca C; Departments of Dermatology.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology., LeBoeuf NR; Departments of Dermatology.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology.
Publikováno v:
Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Aug 25; Vol. 48 (9), pp. 1077-1080.
Autor:
Virgen CA; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sparks JA; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA., Nohria A; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA., O'Hare MJ; Harvard Medical School, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Goyal A; Department of Dermatology, University of Minnesota, Minneapolis, MN, USA., Said JT; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Tawa M; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., LeBoeuf NR; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kupper TS; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fisher DC; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Larocca C; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
The oncologist [Oncologist] 2023 Aug 03; Vol. 28 (8), pp. e694-e698.
Autor:
Fay CJ; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Moslehi D; Harvard Medical School, Boston, Massachusetts., Iriarte C; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Dang TM; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Virgen CA; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Russell-Goldman E; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JAAD case reports [JAAD Case Rep] 2023 Jul 07; Vol. 39, pp. 74-77. Date of Electronic Publication: 2023 Jul 07 (Print Publication: 2023).
Autor:
Virgen CA; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Sanchez II; Department of Dermatology, University of California, Irvine, Irvine, California., Elsensohn AN; Department of Dermatology, Loma Linda University, Loma Linda, California., Kraus CN; Department of Dermatology, University of California, Irvine, Irvine, California.
Publikováno v:
International journal of women's dermatology [Int J Womens Dermatol] 2023 Mar 08; Vol. 9 (1), pp. e078. Date of Electronic Publication: 2023 Mar 08 (Print Publication: 2023).
Autor:
Gupta N; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Case Western Reserve University School of Medicine, Cleveland, Ohio., Virgen CA; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Goyal A; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Lane AA; Harvard Medical School, Boston, Massachusetts.; Blastic Plasmacytoid Dendritic Cell Neoplasm Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Antin JH; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston, Massachusetts., Divito SJ; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Larocca C; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JAAD case reports [JAAD Case Rep] 2023 Jan 28; Vol. 33, pp. 67-69. Date of Electronic Publication: 2023 Jan 28 (Print Publication: 2023).
Autor:
Plumptre IR; Imperial College Healthcare NHS Trust, London, UK., Said JT; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Sun T; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Larocca C; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Virgen CA; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kupper TS; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fisher DC; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Devlin PM; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA., Elco CP; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Song JS; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (12), pp. 2832-2846. Date of Electronic Publication: 2022 Jul 21.
Autor:
Sattler S; Albany Medical College, Albany, New York., Kraus CN; Department of Dermatology, University of California, Irvine, California., Virgen CA; Department of Dermatology, Center for Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Elsensohn AN; Department of Dermatology, Loma Linda University, Loma Linda, California. Electronic address: aelsensohn@llu.edu.
Publikováno v:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Oct; Vol. 87 (4), pp. 925-927. Date of Electronic Publication: 2022 Jan 05.